Abstract
Purpose
Fluorescence-guided-surgery offers intraoperative visualization of neoplastic tissue. Delta-aminolevulinic acid (5-ALA), which targets enzymatic abnormality in neoplastic cells, is the only approved agent for fluorescence-guided neurosurgery. More recently, we described Second Window Indocyanine Green (SWIG) which targets neoplastic tissue through enhanced vascular permeability. We hypothesized that SWIG would demonstrate similar clinical utility in identification of high-grade gliomas compared with 5-ALA.
Procedures
Female C57/BL6 and nude/athymic mice underwent intracranial implantation of 300,000 GL261 and U87 cells, respectively. Tumor-bearing mice were euthanized after administration of 5-ALA (200 mg/kg intraperitoneal) and SWIG (5 mg/kg intravenous). Brain sections were imaged for protoporphyrin-IX and ICG fluorescence. Fluorescence and H&E images were registered using semi-automatic scripts for analysis. Human subjects with HGG were administered SWIG (2.5 mg/kg intravenous) and 5-ALA (20 mg/kg oral). Intraoperatively, tumors were imaged for ICG and protoporphyrin-IX fluorescence.
Results
In non-necrotic tumors, 5-ALA and SWIG demonstrated 90.2 % and 89.2 % tumor accuracy (p value = 0.52) in U87 tumors and 88.1 % and 87.7 % accuracy (p value = 0.83) in GL261 tumors. The most distinct difference between 5-ALA and SWIG distribution was seen in areas of tumor-associated necrosis, which often showed weak/no protoporphyrin-IX fluorescence, but strong SWIG fluorescence. In twenty biopsy specimens from four subjects with HGG, SWIG demonstrated 100 % accuracy, while 5-ALA demonstrated 75–85 % accuracy; there was 90 % concordance between SWIG and 5-ALA fluorescence.
Conclusion
Our results provide the first direct comparison of the diagnostic utility of SWIG vs 5-ALA in both rodent and human HGG. Given the broader clinical utility of SWIG compared with 5-ALA, our data supports the use of SWIG in tumor surgery to improve the extent of safe resections.
Clinical Trial
NCT02710240 (US National Library of Medicine Registry; https://www.clinicaltrials.gov/ct2/show/NCT02710240?id=NCT02710240&draw=2&rank=1).
Similar content being viewed by others
Abbreviations
- 5-ALA:
-
Delta-aminolevulinic-acid
- FGS:
-
Fluorescence-guided surgery
- H&E:
-
Hematoxylin and eosin
- HGG:
-
High-grade glioma
- ICG:
-
Indocyanine green
- MRI:
-
Magnetic resonance imaging
- NIR:
-
Near-infrared
- NPV:
-
Negative predictive value
- PpIX:
-
Protoporphyrin-IX
- ROC:
-
Receiver operating characteristic
- ROI:
-
Region of interest
- SBR:
-
Signal to background ratio
- SWIG:
-
Second Window Indocyanine Green
References
Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, Lang FF, McCutcheon IE, Hassenbusch SJ, Holland E, Hess K, Michael C, Miller D, Sawaya R (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190–198
Sanai N, Polley M-Y, McDermott MW, Parsa AT, Berger MS (2011) An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 115:3–8
Wirtz CR et al (2000) The benefit of neuronavigation for neurosurgery analyzed by its impact on glioblastoma surgery. Neurol Res 22:354–360
Sherman JH, Hoes K, Marcus J, Komotar RJ, Brennan CW, Gutin PH (2011) Neurosurgery for brain tumors: update on recent technical advances. Curr Neurol Neurosci Rep 11:313–319
Berkmann S, Schlaffer S, Nimsky C, Fahlbusch R, Buchfelder M (2014) Intraoperative high-field MRI for transsphenoidal reoperations of nonfunctioning pituitary adenoma. J Neurosurg 121:1–10
Kuo JS, Barkhoudarian G, Farrell CJ, Bodach ME, Tumialan LM, Oyesiku NM, Litvack Z, Zada G, Patil CG, Aghi MK (2016) Congress of Neurological Surgeons systematic review and evidence-based guideline on surgical techniques and Technologies for the Management of patients with nonfunctioning pituitary adenomas. Neurosurgery 79:E536–E538
Sheehan J et al (2016) Congress of neurological surgeons systematic review and evidence-based guideline for the management of patients with residual or recurrent nonfunctioning pituitary adenomas. Neurosugery 79:539–540
Stummer W et al (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392–401
Stummer W et al (1998) Intraoperative detection of malignant gliomas by 5-aminolevulinic acid-induced porphyrin fluorescence. Neurosurgery 42:518–525; discussion 525–6
Stepp H, Stummer W (2018) 5-ALA in the management of malignant glioma. Lasers Surg Med 50:399–419
Coburger J, Engelke J, Scheuerle A, Thal DR, Hlavac M, Wirtz CR, König R (2014) Tumor detection with 5-aminolevulinic acid fluorescence and Gd-DTPA–enhanced intraoperative MRI at the border of contrast-enhancing lesions: a prospective study based on histopathological assessment. Neurosurg Focus 36:E3. https://doi.org/10.3171/2013.11.FOCUS13463
Teraphongphom N, Kong CS, Warram JM, Rosenthal EL (2017) Specimen mapping in head and neck cancer using fluorescence imaging. Laryngoscope Investig Otolaryngol 2:447–452
Frangioni JV (2003) In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 7:626–634
Kim Y, Jeong S, Jun BH, Lee YS, Lee YS, Jeong DH, Lee DS (2017) Endoscopic imaging using surface-enhanced Raman scattering. Eur J Nanomed 9
Blomfield J, Farrar JF (1969) The fluorescent properties of maturing arterial elastin. Cardiovasc Res 3:161–170
Zhang DY, Singhal S, Lee JYK (2018) Optical principles of fluorescence-guided brain tumor surgery: a practical primer for the neurosurgeon. Neurosurgery 85:312–324. https://doi.org/10.1093/neuros/nyy315
Dijkstra BM, Motekallemi A, den Dunnen WFA, Jeltema JR, van Dam GM, Kruyt FAE, Groen RJM (2018) SSTR-2 as a potential tumour-specific marker for fluorescence-guided meningioma surgery. Acta Neurochir 160(1539–1546):1539–1546
Rosenthal EL, Warram JM, de Boer E, Chung TK, Korb ML, Brandwein-Gensler M, Strong TV, Schmalbach CE, Morlandt AB, Agarwal G, Hartman YE, Carroll WR, Richman JS, Clemons LK, Nabell LM, Zinn KR (2015) Safety and tumor specificity of cetuximab-IRDye800 for surgical navigation in head and neck cancer. Clin Cancer Res 21:3658–3666
Elliott JT, Marra K, Evans LT, Davis SC, Samkoe KS, Feldwisch J, Paulsen KD, Roberts DW, Pogue BW (2017) Simultaneous in vivo fluorescent markers for perfusion, protoporphyrin metabolism and EGFR expression for optically guided identification of orthotopic glioma HHS Public Access. Clin Cancer Res 23:2203–2212
Miller SE, Tummers WS, Teraphongphom N, van den Berg NS, Hasan A, Ertsey RD, Nagpal S, Recht LD, Plowey ED, Vogel H, Harsh GR, Grant GA, Li GH, Rosenthal EL (2018) First-in-human intraoperative near-infrared fluorescence imaging of glioblastoma using cetuximab-IRDye800. J Neuro-Oncol 139:135–143
Predina JD, Newton AD, Keating J, Barbosa EM Jr, Okusanya O, Xia L, Dunbar A, Connolly C, Baldassari MP, Mizelle J, Delikatny EJ, Kucharczuk JC, Deshpande C, Kularatne SA, Low P, Drebin J, Singhal S (2017) Intraoperative molecular imaging combined with positron emission tomography improves surgical management of peripheral malignant pulmonary nodules. Ann Surg 266:479–488
Predina JD, Newton A, Deshpande C, Low P, Singhal S (2018) Utilization of targeted near-infrared molecular imaging to improve pulmonary metastasectomy of osteosarcomas. J Biomed Opt 23:1
Onda N, Kimura M, Yoshida T, Shibutani M (2016) Preferential tumor cellular uptake and retention of indocyanine green for in vivo tumor imaging. Int J Cancer 139:673–682
Lee JYK, Thawani JP, Pierce J, Zeh R, Martinez-Lage M, Chanin M, Venegas O, Nims S, Learned K, Keating J, Singhal S (2016) Intraoperative near-infrared optical imaging can localize gadolinium-enhancing gliomas during surgery. Neurosurgery 79:856–871. https://doi.org/10.1227/NEU.0000000000001450
Cho SS, Salinas R, Lee JYK (2019) Indocyanine-green for fluorescence-guided surgery of brain tumors: evidence, techniques, and practical experience. Front Surg 6:11
Lee JYK, Pierce JT, Thawani JP, Zeh R, Nie S, Martinez-Lage M, Singhal S (2018) Near-infrared fluorescent image-guided surgery for intracranial meningioma. J Neurosurg 128:380–390
Lee JYK, Pierce JT, Zeh R, Cho SS, Salinas R, Nie S, Singhal S (2017) Intraoperative near-infrared optical contrast can localize brain metastases. World Neurosurg 106:120–130
Cho SS et al (2018) Intraoperative near-infrared imaging with receptor-specific versus passive delivery of fluorescent agents in pituitary adenomas. J Neurosurg. https://doi.org/10.3171/2018.7.JNS181642
Jeon JW, Cho SS, Nag S, Buch L, Pierce J, Su YRS, Adappa ND, Palmer JN, Newman JG, Singhal S, Lee JYK (2019) Near-infrared optical contrast of skull base tumors during endoscopic endonasal surgery. Oper Neurosurg 17:32–42
Baumann BC, Dorsey JF, Benci JL, Joh DY, Kao GD (2012) Stereotactic intracranial implantation and in vivo bioluminescent imaging of tumor xenografts in a mouse model system of glioblastoma multiforme. J Vis Exp. https://doi.org/10.3791/4089
Dsouza AV, Lin H, Henderson ER, Samkoe KS, Pogue BW (2016) Review of fluorescence guided surgery systems: identification of key performance capabilities beyond indocyanine green imaging. J Biomed Opt 1
Cho SS, Zeh R, Pierce JT, Salinas R, Singhal S, Lee JYK (2018) Comparison of near-infrared imaging camera Systems for Intracranial Tumor Detection. Mol Imaging Biol 20:213–220
Roberts DW, Valdés PA, Harris BT, Fontaine KM, Hartov A, Fan X, Ji S, Lollis SS, Pogue BW, Leblond F, Tosteson TD, Wilson BC, Paulsen KD (2011) Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid–induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. J Neurosurg 114:595–603
Mayhan WG (2002) Cellular mechanisms by which tumor necrosis factor-alpha produces disruption of the blood-brain barrier. Brain Res 927:144–152
Kobayashi M, Shimizu Y, Shibata N, Uchiyama S (2014) Gadolinium enhancement patterns of tumefactive demyelinating lesions: correlations with brain biopsy findings and pathophysiology. J Neurol 261:1902–1910
Reyes R, Guo M, Swann K, Shetgeri SU, Sprague SM, Jimenez DF, Barone CM, Ding Y (2009) Role of tumor necrosis factor–α and matrix metalloproteinase–9 in blood-brain barrier disruption after peripheral thermal injury in rats. J Neurosurg 110:1218–1226
Hitti FL, Lee JYK (2018) Endoscopic resection of an intraventricular tumor with Second Window Indocyanine Green: 2-dimensional operative video. Oper Neurosurg (Hagerstown, Md) 15:E53–E54
Roberts DW, Olson JD, Evans LT, Kolste KK, Kanick SC, Fan X, Bravo JJ, Wilson BC, Leblond F, Marois M, Paulsen KD (2018) Red-light excitation of protoporphyrin IX fluorescence for subsurface tumor detection. J Neurosurg 128:1690–1697
Kaibori M et al (2016) Intraoperative detection of superficial liver tumors by fluorescence imaging using indocyanine green and 5-aminolevulinic acid. Anticancer Res 36:1841–1849
van Dam GM et al (2011) Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-alpha targeting: first in-human results. Nat Med 17:1315–1319
Predina JD, Newton AD, Keating J, Dunbar A, Connolly C, Baldassari M, Mizelle J, Xia L, Deshpande C, Kucharczuk J, Low PS, Singhal S (2018) A phase I clinical trial of targeted intraoperative molecular imaging for pulmonary adenocarcinomas. Ann Thorac Surg 105:901–908
Predina JD, Newton AD, Xia L, Corbett C, Connolly C, Shin M, Sulyok LF, Litzky L, Deshpande C, Nie S, Kularatne SA, Low PS, Singhal S (2018) An open label trial of folate receptor-targeted intraoperative molecular imaging to localize pulmonary squamous cell carcinomas. Oncotarget 9:13517–13529
Predina JD, Newton A, Corbett C, Xia L, Sulyok LF, Shin M, Deshpande C, Litzky L, Barbosa E, Low PS, Kucharczuk JC, Singhal S (2018) Localization of pulmonary ground-glass opacities with folate receptor–targeted intraoperative molecular imaging. J Thorac Oncol 13:1028–1036
Predina JD, Newton AD, Connolly C, Dunbar A, Baldassari M, Deshpande C, Cantu E III, Stadanlick J, Kularatne SA, Low PS, Singhal S (2018) Identification of a folate receptor-targeted near-infrared molecular contrast agent to localize pulmonary adenocarcinomas. Mol Ther 26:390–403
Roy J, Kaake M, Low PS (2019) Small molecule targeted NIR dye conjugate for imaging LHRH receptor positive cancers. Oncotarget 10:152–160
Lee JYK, Cho SS, Stummer W, Tanyi JL, Vahrmeijer AL, Rosenthal E, Smith B, Henderson E, Roberts DW, Lee A, Hadjipanayis CG, Bruce JN, Newman JG, Singhal S (2019) Review of clinical trials in intraoperative molecular imaging during cancer surgery. J Biomed Opt 24:1–8
Pagoto A, Garello F, Marini GM, Tripepi M, Arena F, Bardini P, Stefania R, Lanzardo S, Valbusa G, Porpiglia F, Manfredi M, Aime S, Terreno E (2020) Novel gastrin-releasing peptide receptor targeted near-infrared fluorescence dye for image-guided surgery of prostate cancer. Mol Imaging Biol 22:85–93
Yazaki PJ, Lwin TM, Minnix M, Li L, Sherman A, Molnar J, Miller A, Frankel P, Chea J, Poku E, Bowles N, Hoffman RM, Shively JE, Bouvet M (2019) Improved antibody-guided surgery with a near-infrared dye on a pegylated linker for CEA-positive tumors. J Biomed Opt 24:1
Maire CL, Ligon KL (2014) Molecular pathologic diagnosis of epidermal growth factor receptor. Neuro-Oncology 16 Suppl 8:viii1–viii6
Keating J, Newton A, Venegas O, Nims S, Zeh R, Predina J, Deshpande C, Kucharczuk J, Nie S, Delikatny EJ, Singhal S (2017) Near-infrared intraoperative molecular imaging can locate metastases to the lung. Ann Thorac Surg 103:390–398
Valdés PA, Jacobs V, Harris BT, Wilson BC, Leblond F, Paulsen KD, Roberts DW (2015) Quantitative fluorescence using 5-aminolevulinic acid-induced protoporphyrin IX biomarker as a surgical adjunct in low-grade glioma surgery. J Neurosurg 123:771–780
Stummer W, Tonn JC, Goetz C, Ullrich W, Stepp H, Bink A, Pietsch T, Pichlmeier U (2014) 5-Aminolevulinic acid-derived tumor fluorescence. Neurosurgery 74:310–320
Conflict of interest
JYKL has had stock options in VisionSense in the past. No other authors declare that they disclosures or conflicts of interest.
Disclaimer
The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Funding
Financial Support: Supported in part by the National Institutes of Health R01 CA193556 (SS), and the Institute for Translational Medicine and Therapeutics of the Perelman School of Medicine at the University of Pennsylvania (JYKL). Research reported in this publication was also supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number UL1TR000003 (JYKL). In addition, research reported in this publication was supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under award number TL1TR001880 (SSC). Authorship Statement
All authors have read and approved this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All animal procedures were conducted according to a protocol approved by the Institutional Animal Care and Use Committee at the University of Pennsylvania (#805979) and NIH and ARRIVE guidelines. The clinical trial was approved by the University of Pennsylvania’s Institutional Review Board (NCT02710240).
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Cho, S.S., Sheikh, S., Teng, C.W. et al. Evaluation of Diagnostic Accuracy Following the Coadministration of Delta-Aminolevulinic Acid and Second Window Indocyanine Green in Rodent and Human Glioblastomas. Mol Imaging Biol 22, 1266–1279 (2020). https://doi.org/10.1007/s11307-020-01504-w
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11307-020-01504-w